Country: Canada
Language: English
Source: Health Canada
FUSIDATE SODIUM
LEO PHARMA INC
J01XC01
FUSIDIC ACID
250MG
TABLET
FUSIDATE SODIUM 250MG
ORAL
100
Prescription
OTHER MISCELLANEOUS ANTIBACTERIAL AGENTS*
Active ingredient group (AIG) number: 0114229002; AHFS:
CANCELLED POST MARKET
2009-06-05
PRODUCT MONOGRAPH PR FUCIDIN® Sodium fusidate Film Coated Tablets, 250 mg Antibiotic LEO Pharma Inc. Thornhill, Ontario L3T 7W8 www.leo-pharma.com/canada Date of Revision: FEBRUARY 16, 2010 Submission Control No: 134282 ®Registered trademark of LEO Pharma A/S used under license by LEO Pharma Inc., Thornhill, ON LEO® _ _ _FUCIDIN® (sodium fusidate) Product Monograph, version 2.0_ _Page 2_ _ of _ _30_ NAME OF DRUG PR FUCIDIN® Sodium fusidate Film Coated Tablets, 250 mg THERAPEUTIC CLASSIFICATION Antibiotic ACTION The antibacterial action of fusidic acid results from the inhibition of bacterial protein synthesis. The drug interferes with amino acid transfer from aminoacyl-tRNA to proteins undergoing biosynthetic process on the ribosomes. Although bacterial cells stop dividing almost within two minutes after contact with the antibiotic in vitro, DNA and RNA synthesis continue for 45 minutes and 1-2 hours, respectively. (13,37,38,45) CLINICAL PHARMACOLOGY Fusidic acid is active against a wide range of gram positive organisms, particularly staphylococci. (2,10) Other species against which fusidic acid exerts high clinical activity include Streptococci, (including Pneumococci) and Corynebacteria. (2,10,14) Fusidic acid is virtually inactive against most gram negative bacteria. The differences in activity against gram negative and gram positive organisms are believed to be due to a difference in cell LEO® _ _ _FUCIDIN® (sodium fusidate) Product Monograph, version 2.0_ _Page 3_ _ of _ _30_ wall permeability. Mammalian cells are much less susceptible to inhibition of protein synthesis by FUCIDIN (fusidic acid) than sensitive bacterial cells. These differences are believed to be due primarily to a difference in cell wall permeability. No cross-resistance has been observed to date between FUCIDIN and other antibiotics presently in clinical use. CLINICAL PHARMACOKINETICS FUCIDIN (fusidic acid) has a somewhat steroid like structure but does not exhibit any steroid like pharmacological activity (ie. hormonal or anti-infl Read the complete document